Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors

Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors

Item
http://www.wikidata.org/entity/Q37311579
Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma.Clinical trials of tyrosine kinase inhibitors for lung cancer in China: a reviewAC-93253 iodide, a novel Src inhibitor, suppresses NSCLC progression by modulating multiple Src-related signaling pathways.Inhibition of coiled coil domain containing protein 69 enhances platinum-induced apoptosis in ovarian cancer cells.Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model.Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets and strategies.Influences of Anlotinib on Cytochrome P450 Enzymes in Rats Using a Cocktail Method.Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor.Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302).Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas.Hypertension in malignancy-an underappreciated problem.Impaired tumor growth and angiogenesis in mice heterozygous for Vegfr2 (Flk1)Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical developmentAntitumor effects of anlotinib in thyroid cancer
P2860

Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors

Item
http://www.wikidata.org/entity/Q37311579
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety, pharmacokinetics, and ...... vanced refractory solid tumors
@en
Safety, pharmacokinetics, and ...... anced refractory solid tumors.
@nl
type
label
Safety, pharmacokinetics, and ...... vanced refractory solid tumors
@en
Safety, pharmacokinetics, and ...... anced refractory solid tumors.
@nl
prefLabel
Safety, pharmacokinetics, and ...... vanced refractory solid tumors
@en
Safety, pharmacokinetics, and ...... anced refractory solid tumors.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P932
P356
P1433
P1476
Safety, pharmacokinetics, and ...... vanced refractory solid tumors
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P932